VANCOUVER,
BC -- February 19, 2020 -- Nextleaf Solutions Ltd.
("Nextleaf", "OILS", or the
"Company") (CSE: OILS) (OTCQB: OILFF) (FSE:
L0MA), Canada’s most innovative cannabis
extractor, announced today that the Canadian Intellectual
Property Office has granted the Company its 13th issued
patent. This patent pertains to a proprietary
closed loop chilled solvent feed apparatus for cannabinoid
extraction, and mirrors a patent previously granted by the United
States Patent and Trademark Office on November 19,
2019.
"When Nextleaf
obtained the first patent for the industrial-scale extraction and
purification of cannabinoids," said Taran Grey, Director of
Intellectual Property, "it broadcast our teams' demonstrable talent
for innovation. To provide greater certainty of that talent, we
have now repeated the accomplishment a dozen more times in four
jurisdictions, with further patents expected to be granted
shortly."
In an
environment where Life Science patent applications have a pending
to issuance success rate of less than 50%, Nextleaf's 100% success
rate is unparalleled.
OILS is focused
on commercializing its patent portfolio by licensing IP to partners
operating in other legal markets, and supplying THC and CBD oils to
qualified partners through Nextleaf Labs Ltd., a Health Canada
licensed Standard Processor. The Company commenced revenue in
December 2019.
Nextleaf Solutions to Present at the Third Annual
Gravitas Growth
Conference
OILS will be
participating in the 3rd Annual Gravitas Growth Conference taking
place February 20th, 2020 at the Fairmont Pacific Rim Hotel in
Vancouver, BC.
Nextleaf CEO, Paul Pedersen, is scheduled to present on Thursday,
February 20th at 2:35 PM PST.
"I look forward to sharing our plans for 2020
at the Gravitas Growth Conference" said
Pedersen.
The Gravitas Growth Conference
features 18 companies and is expected to be attended by over 250
individuals. For additional details about the conference and
Gravitas Securities Inc., please
visit: www.gravitassecurities.com.
About Nextleaf Solutions
OILS is developing
disruptive intellectual property for extraction, purification, and
formulation of cannabinoids. The Company owns a portfolio of
13 issued patents pertaining to the industrial-scale
production of high-purity, cannabinoid-rich distillate, the key
ingredient used in the manufacturing of standardized THC and CBD
based products. Nextleaf Solutions commercializes its intellectual
property portfolio through IP licensing, and supplying THC and CBD
oils through Nextleaf Labs, a Health Canada licensed Standard
Processor.
Nextleaf Solutions
trades as OILS
on the Canadian Securities Exchange,
OILFF on the OTCQB Market in the United
States, and L0MA on the Frankfurt Stock
Exchange.
Follow OILS across social media
platforms: Twitter, LinkedIn, Facebook, and Instagram.
www.nextleafsolutions.com
For further information, please contact:
604-283-2301 (ext. 201)
investors@nextleafsolutions.com
On behalf of the Board of Directors of the
Company,
Paul Pedersen,
CEO
CAUTIONARY
STATEMENT:
Certain statements contained
in this press release constitute “forward-looking statements”. All
statements other than statements of historical fact contained in
this press release, including, without limitation, those regarding
the Company’s ability to capitalize on its IP portfolio and enter
into agreements with third parties, expected market growth, and the
Company’s strategy, plans, objectives, goals and targets, and
any statements preceded by, followed by or that include the words
“believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”,
“may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”,
“project”, “seek”, “should” or similar expressions or the negative
thereof, are forward-looking statements. These statements are not
historical facts but instead represent only the Company’s
expectations, estimates and projections regarding future events.
These statements are not guarantees of future performance and
involve assumptions, risks and uncertainties that are difficult to
predict. Therefore, actual results may differ materially from what
is expressed, implied or forecasted in such forward-looking
statements. Additional factors that could cause actual results,
performance or achievements to differ materially include, but are
not limited to the risk factors discussed in the Company’s MD&A
for the most recent fiscal period. Management provides
forward-looking statements because it believes they provide useful
information to investors when considering their investment
objectives and cautions investors not to place undue reliance on
forward-looking information. Consequently, all of the
forward-looking statements made in this press release are qualified
by these cautionary statements and other cautionary statements or
factors contained herein, and there can be no assurance that the
actual results or developments will be realized or, even if
substantially realized, that they will have the expected
consequences to, or effects on, the Company. These forward-looking
statements are made as of the date of this press release and the
Company assumes no obligation to update or revise them to reflect
subsequent information, events or circumstances or otherwise,
except as required by law. The CSE has not
reviewed, approved or disapproved the contents of this press
release.
